Aristotle University Of Thessaloniki (AUTH)
Φαρμακοχημική μελέτη κινναμωμικών υβριδίων με βιολογικό ενδιαφέρον
Abstract
dc:descriptionChronic inflammation plays a pivotal role in the pathogenesis and progression of several multifactorial diseases, including cancer, diabetes, arthritis, cardiovascular disorders, Alzheimer’s disease, and autoimmune conditions. Cyclooxygenases (COXs) and lipoxygenases (LOXs) are among the key enzymes involved in the initiation and maintenance of inflammatory processes and constitute important pharmacological targets. In recent years, cinnamic acid–based hybrid molecules, particularly those incorporating a nitric oxide (NO) donor moiety, have attracted significant attention as potential therapeutic agents for the treatment of multifactorial diseases. In the present study, novel cinnamic acid–nitric oxide (NO) donor hybrids were synthesized as multitarget agents and evaluated for their antioxidant, anti-inflammatory, and cytotoxic properties. Specifically, hybrids 5a–i, 6a–i, 9a–i , 19a, 24a, 28 και 31 were synthesized and assessed as inhibitors of lipid peroxidation and LOX activity, while selected compounds were further evaluated for their inhibitory effects against COX-1and COX-2. In addition, hybrids 6a–i, 9a–i , 19a, 24a, 28 και 31, which contain an NO do nor moiety, were examined for their ability to inhibit albumin denaturation and to release nitric oxide. The results demonstrated that compound 9a represents a highly promising multitarget agent, as it exhibited the lowest IC₅₀ value for LOX inhibition, significant antioxidant activity, and the highest NO-releasing capacity. Furthermore, compound 9e showed notable inhibitory activity against both COX-2 and LOX, indicating its potential as a dual COX–LOX inhibitor. Moreover, compound 6i displayed the strongest cytotoxic activity among the tested compounds, with EC₅₀ values ranging from 36 to 45 μM across several cancer cell lines. Finally, all synthesized compounds were subjected to in silico studies, which supported the experimental findings and provided valuable insights into their pharmacokinetic and pharmacodynamic profiles.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsopka, Ioanna-Chrysoula
- Τσόπκα, Ιωάννα-Χρυσούλα
Subjects
dc:subject × 24- Χρόνια φλεγμονή
- Κινναμωμικό οξύ
- Υβριδικά μόρια
- Δότες μονοξειδίου του αζώτου (NO)
- Λιποξυγονάση (LOX)
- Κυκλοξυγονάσες (COX-1/COX-2)
- Αντιοξειδωτική δράση
- Αντιφλεγμονώδης δράση
- Κυτταροτοξική και αντικαρκινική δράση
- Chronic inflammation
- Cinnamic acid
- Hybrid molecules
- Nitric oxide (NO) donors
- Lipoxygenase (LOX)
- Cyclooxygenases (COX-1/COX-2)
- Antioxidant activity
- Anti-inflammatory activity
- Cytotoxic and anticancer activity
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, άλλοι τομείς
- Health Sciences
- Medical and Health Sciences
- Health sciences, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62049